tiprankstipranks
Trending News
More News >
Paradigm Biopharmaceuticals Ltd. (AU:PAR)
ASX:PAR

Paradigm Biopharmaceuticals (PAR) Similar Shares

Compare
39 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Paradigm Biopharmaceuticals
AU$0.32
$137.13M
-6.44
-14.67%
1 Buy
0 Hold
0 Sell
Moderate Buy
Imugene
AU$0.30
AU$96.19M
-0.96
-75.08%
1 Buy
0 Hold
0 Sell
Moderate Buy
Alterity Therapeutics
AU$0.01
AU$87.00M
0.00%
1 Buy
0 Hold
0 Sell
Moderate Buy
Pharmaust Limited
AU$0.11
€58.82M
-3.24
-33.33%
2 Buy
0 Hold
0 Sell
Moderate Buy
Recce Pharmaceuticals Ltd.
AU$0.41
AU$172.06M
-6.60
35.23%
Arovella Therapeutics Limited
AU$0.08
AU$91.29M
-11.18
-55.29%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
AU:PAR
Paradigm Biopharmaceuticals
0.32
-0.07
-17.95%
AU:IMU
Imugene
0.31
-0.95
-75.76%
AU:ATH
Alterity Therapeutics
0.01
0.00
0.00%
AU:NUZ
Pharmaust Limited
0.11
-0.06
-33.33%
AU:RCE
Recce Pharmaceuticals Ltd.
0.60
0.15
33.33%
AU:ALA
Arovella Therapeutics Limited
0.08
-0.08
-50.00%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts